| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/23/2005 | CN1599609A Combination of a selective PDE4 inhibitor and an adrenergic beta-2 receptor agonist |
| 03/23/2005 | CN1599604A Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 03/23/2005 | CN1597964A Expression and purification of M protein in recombined SARS coronary virus |
| 03/23/2005 | CN1597693A Antigen analogue epi-peptide of para bacillus fowl blood phili and its use |
| 03/23/2005 | CN1596982A Composition of nanometer SOD and astragalus root or its extract and its preparation method |
| 03/23/2005 | CN1596979A Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 03/23/2005 | CN1596973A Interferon-ginseng diol saponin slow-releasing tablet |
| 03/23/2005 | CN1596963A Plaster for treating cough and panting |
| 03/23/2005 | CN1596952A Medicine for treating lung carbuncle disease |
| 03/23/2005 | CN1596926A Composition for preventing SARS and homologous SARS syndrome |
| 03/23/2005 | CN1596925A Composition for treating and/or relaxing SARS and SARS kind syndrome |
| 03/23/2005 | CN1596924A Chinese and western modicinal compound formula for treating oral cavity throat disease |
| 03/23/2005 | CN1596922A Compound medicine of sweet lozenge for moistening throat and its preparation method |
| 03/23/2005 | CN1596890A Medicine having antivirus action |
| 03/23/2005 | CN1596888A Application of dihydromyricetrin |
| 03/23/2005 | CN1596886A Application of albi multisulfoxide and its salt in preparing medicine for preventing and treating respiratory tract virus infestation |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/23/2005 | CN1193777C Chinese medicine for treaing cold by omphalotherapy and its preparing process |
| 03/23/2005 | CN1193773C Capsule agent of chanhua mycelia and preparing method thereof |
| 03/23/2005 | CN1193758C Preparation of theophylline or aminophylline supplied through skin for treating respiratory disease as well as its preparing method |
| 03/23/2005 | CN1193746C Substituted nitrobenzene derimative for medicine and other use |
| 03/22/2005 | US6869975 Linked biaryl compounds |
| 03/22/2005 | US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 03/22/2005 | US6869968 Such as 3-(4-fluorophenyl)-4-(4-methysulphonylphenyl)-2-(3H)-oxazolone; for treating colorectal cancer, fevers, and inflammation |
| 03/22/2005 | US6869962 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/22/2005 | US6869960 Substituted with a quinolin-3-ylmethyl- group, e.g., 2,3-dihydro-1'-((2-oxo-1,2,3,4-tetrahydro-3-quinolinyl)-methyl)spiro(1H -indene-1,4'-piperidine) |
| 03/22/2005 | US6869956 Such as 4-(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a) quinoxaline; kits; treating arthritis, psoriasis, inflammatory bowel disease, autoimmune diseases and neurodegenerative diseases among others |
| 03/22/2005 | US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer |
| 03/22/2005 | US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents |
| 03/22/2005 | US6869942 Comprises formoterol and corticosteroid; for use in treatment of respiratory disorders such as asthma, rhinitis and chronic obstructive pulmonary disease |
| 03/22/2005 | CA2257772C Bicyclic¬3.1.0|hexanes and related compounds |
| 03/17/2005 | WO2005023771A1 Chemokine receptor antagonist and medical use thereof |
| 03/17/2005 | WO2005023269A1 Medicament compositions comprising a heterocyclic compound and an anticholinergic |
| 03/17/2005 | WO2005023241A1 The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| 03/17/2005 | WO2005023240A2 Pharmaceutical combination preparation containing glycyrrhizine, zinc, and a compound comprising a thiol group or a group that is metabolized thereto |
| 03/17/2005 | WO2005023238A1 Erg channel openers for the treatment of hyperexcitability-related neuronal diseases |
| 03/17/2005 | WO2005023236A1 Phenylephrine tannate, pyrilamine tannate, and dextromethorphan tannate salts in pharmaceutical compositions |
| 03/17/2005 | WO2005012543A3 Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation |
| 03/17/2005 | WO2004103364A3 Treatment of respiratory disease by inhalation of synthetic matrix metalloprotease inhibitors |
| 03/17/2005 | WO2004069165A3 Methods and compositions for the treatment of gastrointestinal disorders |
| 03/17/2005 | WO2004056809A8 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 03/17/2005 | WO2004056808A8 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 03/17/2005 | WO2004032843A3 Mucoadhesive tetracycline formulations |
| 03/17/2005 | WO2003043619A8 New use for the treatment of gastroesophageal reflux disease |
| 03/17/2005 | WO2002072571A8 Pyridinyl pyrazoles useful for the treatment of copd |
| 03/17/2005 | WO2002050028A8 Substituted benzoindoles as spla2 inhibitors |
| 03/17/2005 | US20050059726 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; 6-Chloro-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)-1,1'-biphenyl-4-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide for example |
| 03/17/2005 | US20050059700 Reacting compunds such as 6-methyl-12-oxa-tricyclo[8.2.1.0]trideca-2,4,6-trien-11-ol with compounds such as 4-(2,6-dichloro-phenyl)-piperidine to produce (+-)-cis-1-methyl-7-[[4-(2,6-dichloro-phenyl)piperidin-1-yl)]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol |
| 03/17/2005 | US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors |
| 03/17/2005 | US20050059685 such as R)-1,5-Dimethyl 3-(5-hydroxyhexyl)pyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione, used for the treatment or prevention of symptoms or manifestations associated with diseases or disorders affected by cytokine intracellular signaling |
| 03/17/2005 | US20050059683 A1 adenosine receptor antagonists |
| 03/17/2005 | US20050059666 CCR5 antagonists useful for treating AIDS |
| 03/17/2005 | US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 03/17/2005 | US20050059657 Aminoisoxazole derivatives active as kinase inhibitors |
| 03/17/2005 | US20050059625 Immunostimulatory nucleic acid molecules |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | US20050058667 Adjuvants for use in vaccines |
| 03/17/2005 | US20050058647 Newly identified polypeptide and polynucleotides for diagnosis of new compounds |
| 03/17/2005 | US20050058636 Medicament against thrombotic diseases |
| 03/17/2005 | US20050056281 Medicament container with same side airflow inlet and outlet and method of use |
| 03/17/2005 | CA2535529A1 Phenylephrine tannate, pyrilamine tannate, and dextromethorphan tannate salts in pharmaceutical compositions |
| 03/16/2005 | EP1514877A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process |
| 03/16/2005 | EP1514551A1 Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food |
| 03/16/2005 | EP1514549A1 Powdery respiratory tonic composition |
| 03/16/2005 | EP1514546A1 Medicament compositions based on tiotropium salts and on salmeterol salts |
| 03/16/2005 | EP1514545A1 Use of tolperisone for the treatment of spasms of organes consisting essentially of smooth muscles. |
| 03/16/2005 | EP1514544A1 Antiallergic |
| 03/16/2005 | EP1513870A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same |
| 03/16/2005 | EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/16/2005 | EP1513858A2 Process for the preparation of heterocyclyl substituted adenosine derivatives |
| 03/16/2005 | EP1513839A1 3-substituted quinuclidines and their use |
| 03/16/2005 | EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 03/16/2005 | EP1513834A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 03/16/2005 | EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors |
| 03/16/2005 | EP1513827A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 03/16/2005 | EP1513826A1 New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents |
| 03/16/2005 | EP1513821A1 Protein kinase inhibitors |
| 03/16/2005 | EP1513814A1 Novel piperidine compound |
| 03/16/2005 | EP1513812A1 Substituted indoles |
| 03/16/2005 | EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans |
| 03/16/2005 | EP1513806A1 New salts |
| 03/16/2005 | EP1513557A2 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases |
| 03/16/2005 | EP1513553A1 Methods and materials for treating inflammatory conditions |
| 03/16/2005 | EP1513537A1 Substituted porphyrins |
| 03/16/2005 | EP1513536A1 Use of compounds that stimulate cgmp |
| 03/16/2005 | EP1513531A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 03/16/2005 | EP1513522A2 Methods of treating conditions associated with an edg receptor |
| 03/16/2005 | EP1513520A2 Substituted pyrrolines as kinase inhibitors |
| 03/16/2005 | EP1513516A1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS ANDPROCESSES FOR PREPARING AND THEIR USES |
| 03/16/2005 | EP1513511A1 (2s)-2-amino-4- [2-(ethanimidoylamino)ethyl]thio butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms |
| 03/16/2005 | EP1513509A2 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 03/16/2005 | EP1513502A1 Combination therapy for respiratory disorders |
| 03/16/2005 | EP1513495A1 Modified release pharmaceutical formulation |
| 03/16/2005 | EP1513494A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 03/16/2005 | EP1513419A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/16/2005 | EP1513403A1 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders |
| 03/16/2005 | EP1453510A4 Neurotransmitter balance chemotherapy |
| 03/16/2005 | EP1351962B1 Thienopyrimidine |
| 03/16/2005 | EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/16/2005 | EP1117296B1 Combination of bisphosphonate and tetracycline |